...
首页> 外文期刊>Eukaryotic cell >Incorporation of Ceramides into Saccharomyces cerevisiae Glycosylphosphatidylinositol-Anchored Proteins Can Be Monitored In Vitro
【24h】

Incorporation of Ceramides into Saccharomyces cerevisiae Glycosylphosphatidylinositol-Anchored Proteins Can Be Monitored In Vitro

机译:神经酰胺掺入啤酒酵母糖基磷脂酰肌醇固定蛋白可以进行体外监测。

获取原文
           

摘要

After glycosylphosphatidylinositols (GPIs) are added to GPI proteins of Saccharomyces cerevisiae, a fatty acid of the diacylglycerol moiety is exchanged for a C26:0 fatty acid through the subsequent actions of Per1 and Gup1. In most GPI anchors this modified diacylglycerol-based anchor is subsequently transformed into a ceramide-containing anchor, a reaction which requires Cwh43. Here we show that the last step of this GPI anchor lipid remodeling can be monitored in microsomes. The assay uses microsomes from cells that have been grown in the presence of myriocin, a compound that blocks the biosynthesis of dihydrosphingosine (DHS) and thus inhibits the biosynthesis of ceramide-based anchors. Such microsomes, when incubated with [3H]DHS, generate radiolabeled, ceramide-containing anchor lipids of the same structure as made by intact cells. Microsomes from cwh43Δ or mcd4Δ mutants, which are unable to make ceramide-based anchors in vivo, do not incorporate [3H]DHS into anchors in vitro. Moreover, gup1Δ microsomes incorporate [3H]DHS into the same abnormal anchor lipids as gup1Δ cells synthesize in vivo. Thus, the in vitro assay of ceramide incorporation into GPI anchors faithfully reproduces the events that occur in mutant cells. Incorporation of [3H]DHS into GPI proteins is observed with microsomes alone, but the reaction is stimulated by cytosol or bovine serum albumin, ATP plus coenzyme A (CoA), or C26:0-CoA, particularly if microsomes are depleted of acyl-CoA. Thus, [3H]DHS cannot be incorporated into proteins in the absence of acyl-CoA.
机译:在将糖基磷脂酰肌醇(GPI)添加到酿酒酵母(Semcharomyces cerevisiae)的GPI蛋白中之后,二酰基甘油部分的脂肪酸通过以下步骤被C 26:0 脂肪酸交换: Per1和Gup1。在大多数GPI锚中,此修饰的基于二酰基甘油的锚随后被转化为含神经酰胺的锚,该反应需要Cwh43。在这里,我们显示了可以在微粒体中监测此GPI锚定脂质重塑的最后一步。该测定法使用了在myriocin存在下生长的细胞中的微粒体,myriocin是一种阻止二氢鞘氨醇(DHS)生物合成并因此抑制基于神经酰胺的锚定生物合成的化合物。此类微粒体与[ 3 H] DHS一起孵育时,会生成放射性标记的含神经酰胺的锚定脂质,其结构与完整细胞相同。来自 cwh43 Δ或 mcd4 Δ突变体的微粒体,无法在体内制备基于神经酰胺的锚,不包含[ 3 H] DHS植入体外。此外, gup1 Δ微粒体将[ 3 H] DHS掺入与体内合成的 gup1 Δ细胞相同的异常锚定脂质中。因此,将神经酰胺掺入GPI锚的体外测定忠实地再现了突变细胞中发生的事件。单独用微粒体观察到[ 3 H] DHS掺入GPI蛋白,但细胞溶质或牛血清白蛋白,ATP加辅酶A(CoA)或C 26刺激反应: 0 -CoA,尤其是当微粒体中的酰基CoA耗尽时。因此,在没有酰基辅酶A的情况下,不能将[ 3 H] DHS掺入蛋白质中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号